nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisplatin—urinary bladder cancer—kidney cancer	0.103	0.291	CtDrD
Cisplatin—ATP7B—kidney cancer	0.0994	0.354	CbGaD
Cisplatin—bone cancer—kidney cancer	0.0989	0.279	CtDrD
Cisplatin—testicular cancer—kidney cancer	0.0819	0.231	CtDrD
Cisplatin—lung cancer—kidney cancer	0.0705	0.199	CtDrD
Cisplatin—GSTT1—kidney cancer	0.0497	0.177	CbGaD
Cisplatin—GSTM1—kidney cancer	0.0424	0.151	CbGaD
Cisplatin—GSTP1—kidney cancer	0.0393	0.14	CbGaD
Cisplatin—ABCC6—Dactinomycin—kidney cancer	0.0349	0.16	CbGbCtD
Cisplatin—BCHE—kidney cancer	0.027	0.096	CbGaD
Cisplatin—ABCC6—Vinblastine—kidney cancer	0.0218	0.1	CbGbCtD
Cisplatin—NQO1—Doxorubicin—kidney cancer	0.016	0.0738	CbGbCtD
Cisplatin—ABCC6—Doxorubicin—kidney cancer	0.0134	0.0617	CbGbCtD
Cisplatin—PTGS2—kidney cancer	0.0124	0.0442	CbGaD
Cisplatin—ABCB1—kidney cancer	0.0106	0.0376	CbGaD
Cisplatin—ABCC3—Vincristine—kidney cancer	0.0103	0.0475	CbGbCtD
Cisplatin—XDH—Doxorubicin—kidney cancer	0.00839	0.0386	CbGbCtD
Cisplatin—ABCG2—Pazopanib—kidney cancer	0.00753	0.0346	CbGbCtD
Cisplatin—ABCG2—Dactinomycin—kidney cancer	0.00689	0.0317	CbGbCtD
Cisplatin—ABCC3—Doxorubicin—kidney cancer	0.00645	0.0297	CbGbCtD
Cisplatin—SLC22A2—Vinblastine—kidney cancer	0.00584	0.0269	CbGbCtD
Cisplatin—ABCC2—Paclitaxel—kidney cancer	0.00544	0.025	CbGbCtD
Cisplatin—ABCG2—Erlotinib—kidney cancer	0.00537	0.0247	CbGbCtD
Cisplatin—ABCB1—Temsirolimus—kidney cancer	0.00517	0.0238	CbGbCtD
Cisplatin—ABCG2—Paclitaxel—kidney cancer	0.00492	0.0226	CbGbCtD
Cisplatin—ABCC2—Sorafenib—kidney cancer	0.00483	0.0222	CbGbCtD
Cisplatin—ABCC2—Vinblastine—kidney cancer	0.00477	0.0219	CbGbCtD
Cisplatin—ABCC2—Vincristine—kidney cancer	0.00469	0.0216	CbGbCtD
Cisplatin—ABCG2—Sorafenib—kidney cancer	0.00437	0.0201	CbGbCtD
Cisplatin—ABCG2—Vincristine—kidney cancer	0.00424	0.0195	CbGbCtD
Cisplatin—ABCC2—Sunitinib—kidney cancer	0.00391	0.018	CbGbCtD
Cisplatin—ABCG2—Sunitinib—kidney cancer	0.00354	0.0163	CbGbCtD
Cisplatin—CYP2B6—Sorafenib—kidney cancer	0.00307	0.0141	CbGbCtD
Cisplatin—ABCC2—Doxorubicin—kidney cancer	0.00293	0.0135	CbGbCtD
Cisplatin—CYP2C9—Capecitabine—kidney cancer	0.00292	0.0134	CbGbCtD
Cisplatin—ABCB1—Pazopanib—kidney cancer	0.00271	0.0125	CbGbCtD
Cisplatin—ABCG2—Doxorubicin—kidney cancer	0.00265	0.0122	CbGbCtD
Cisplatin—ABCB1—Dactinomycin—kidney cancer	0.00248	0.0114	CbGbCtD
Cisplatin—GSTT1—urine—kidney cancer	0.0021	0.0698	CbGeAlD
Cisplatin—ABCB1—Gemcitabine—kidney cancer	0.00196	0.00902	CbGbCtD
Cisplatin—ABCB1—Erlotinib—kidney cancer	0.00194	0.00891	CbGbCtD
Cisplatin—CYP2B6—Doxorubicin—kidney cancer	0.00186	0.00857	CbGbCtD
Cisplatin—CYP2C9—Paclitaxel—kidney cancer	0.00183	0.0084	CbGbCtD
Cisplatin—ABCB1—Paclitaxel—kidney cancer	0.00177	0.00815	CbGbCtD
Cisplatin—CYP2C9—Sorafenib—kidney cancer	0.00162	0.00746	CbGbCtD
Cisplatin—ABCB1—Sorafenib—kidney cancer	0.00157	0.00724	CbGbCtD
Cisplatin—ABCB1—Vinblastine—kidney cancer	0.00156	0.00715	CbGbCtD
Cisplatin—GSTM1—urine—kidney cancer	0.00155	0.0514	CbGeAlD
Cisplatin—SLC22A2—nephron—kidney cancer	0.00153	0.0509	CbGeAlD
Cisplatin—ABCB1—Vincristine—kidney cancer	0.00153	0.00703	CbGbCtD
Cisplatin—ABCB1—Sunitinib—kidney cancer	0.00128	0.00587	CbGbCtD
Cisplatin—GSTP1—urine—kidney cancer	0.00097	0.0322	CbGeAlD
Cisplatin—ABCB1—Doxorubicin—kidney cancer	0.000956	0.00439	CbGbCtD
Cisplatin—NQO1—Vincristine—Vinblastine—kidney cancer	0.00078	1	CbGdCrCtD
Cisplatin—MT1A—renal system—kidney cancer	0.000631	0.021	CbGeAlD
Cisplatin—MT1A—kidney—kidney cancer	0.00061	0.0203	CbGeAlD
Cisplatin—CYP4A11—renal system—kidney cancer	0.000581	0.0193	CbGeAlD
Cisplatin—SLC31A2—nephron tubule—kidney cancer	0.000568	0.0189	CbGeAlD
Cisplatin—PTGS2—nephron—kidney cancer	0.000564	0.0187	CbGeAlD
Cisplatin—CYP4A11—kidney—kidney cancer	0.000562	0.0187	CbGeAlD
Cisplatin—CYP4A11—cortex of kidney—kidney cancer	0.000547	0.0182	CbGeAlD
Cisplatin—ATP7B—cortex of kidney—kidney cancer	0.000532	0.0177	CbGeAlD
Cisplatin—MT2A—renal system—kidney cancer	0.000525	0.0175	CbGeAlD
Cisplatin—CYP2C9—urine—kidney cancer	0.000518	0.0172	CbGeAlD
Cisplatin—GSTT1—renal system—kidney cancer	0.000514	0.0171	CbGeAlD
Cisplatin—MT2A—kidney—kidney cancer	0.000508	0.0169	CbGeAlD
Cisplatin—ATP7B—cardiac atrium—kidney cancer	0.000506	0.0168	CbGeAlD
Cisplatin—SLC31A2—kidney—kidney cancer	0.000499	0.0166	CbGeAlD
Cisplatin—GSTT1—kidney—kidney cancer	0.000497	0.0165	CbGeAlD
Cisplatin—SLC31A2—cortex of kidney—kidney cancer	0.000486	0.0162	CbGeAlD
Cisplatin—MT2A—gonad—kidney cancer	0.000471	0.0157	CbGeAlD
Cisplatin—ATP7A—renal system—kidney cancer	0.000455	0.0151	CbGeAlD
Cisplatin—ATP7A—kidney—kidney cancer	0.00044	0.0146	CbGeAlD
Cisplatin—SOD1—nephron tubule—kidney cancer	0.000438	0.0146	CbGeAlD
Cisplatin—ATP7A—cortex of kidney—kidney cancer	0.000428	0.0142	CbGeAlD
Cisplatin—SLC31A1—nephron tubule—kidney cancer	0.000427	0.0142	CbGeAlD
Cisplatin—ABCC6—renal system—kidney cancer	0.000417	0.0139	CbGeAlD
Cisplatin—ABCC6—kidney—kidney cancer	0.000404	0.0134	CbGeAlD
Cisplatin—SLC31A1—renal system—kidney cancer	0.000388	0.0129	CbGeAlD
Cisplatin—XDH—renal system—kidney cancer	0.000383	0.0127	CbGeAlD
Cisplatin—GSTM1—renal system—kidney cancer	0.000379	0.0126	CbGeAlD
Cisplatin—SLC31A1—kidney—kidney cancer	0.000375	0.0125	CbGeAlD
Cisplatin—SOD1—cortex of kidney—kidney cancer	0.000375	0.0125	CbGeAlD
Cisplatin—XDH—kidney—kidney cancer	0.000371	0.0123	CbGeAlD
Cisplatin—GSTM1—kidney—kidney cancer	0.000366	0.0122	CbGeAlD
Cisplatin—SLC31A1—cortex of kidney—kidney cancer	0.000365	0.0121	CbGeAlD
Cisplatin—SOD1—cardiac atrium—kidney cancer	0.000357	0.0118	CbGeAlD
Cisplatin—SLC31A1—gonad—kidney cancer	0.000348	0.0116	CbGeAlD
Cisplatin—SLC31A1—cardiac atrium—kidney cancer	0.000348	0.0115	CbGeAlD
Cisplatin—GSTM1—gonad—kidney cancer	0.00034	0.0113	CbGeAlD
Cisplatin—SLC22A2—nephron tubule—kidney cancer	0.000331	0.011	CbGeAlD
Cisplatin—ABCC5—nephron tubule—kidney cancer	0.000312	0.0104	CbGeAlD
Cisplatin—SLC22A2—renal system—kidney cancer	0.0003	0.00998	CbGeAlD
Cisplatin—NQO1—nephron tubule—kidney cancer	0.000292	0.0097	CbGeAlD
Cisplatin—SLC22A2—kidney—kidney cancer	0.00029	0.00965	CbGeAlD
Cisplatin—SLC22A2—cortex of kidney—kidney cancer	0.000283	0.0094	CbGeAlD
Cisplatin—NQO1—renal system—kidney cancer	0.000266	0.00882	CbGeAlD
Cisplatin—GSTP1—nephron tubule—kidney cancer	0.000261	0.00867	CbGeAlD
Cisplatin—NQO1—kidney—kidney cancer	0.000257	0.00853	CbGeAlD
Cisplatin—ABCC5—cardiac atrium—kidney cancer	0.000254	0.00844	CbGeAlD
Cisplatin—NQO1—cortex of kidney—kidney cancer	0.00025	0.00831	CbGeAlD
Cisplatin—MPO—renal system—kidney cancer	0.000244	0.00811	CbGeAlD
Cisplatin—ABCC3—renal system—kidney cancer	0.000238	0.00792	CbGeAlD
Cisplatin—GSTP1—renal system—kidney cancer	0.000237	0.00788	CbGeAlD
Cisplatin—MPO—kidney—kidney cancer	0.000236	0.00784	CbGeAlD
Cisplatin—ABCC3—kidney—kidney cancer	0.00023	0.00765	CbGeAlD
Cisplatin—GSTP1—kidney—kidney cancer	0.000229	0.00762	CbGeAlD
Cisplatin—GSTP1—cortex of kidney—kidney cancer	0.000223	0.00742	CbGeAlD
Cisplatin—GSTP1—gonad—kidney cancer	0.000213	0.00707	CbGeAlD
Cisplatin—GSTP1—cardiac atrium—kidney cancer	0.000212	0.00706	CbGeAlD
Cisplatin—ABCC2—nephron tubule—kidney cancer	0.000209	0.00696	CbGeAlD
Cisplatin—ABCC2—renal system—kidney cancer	0.00019	0.00633	CbGeAlD
Cisplatin—ABCC2—kidney—kidney cancer	0.000184	0.00612	CbGeAlD
Cisplatin—ABCC2—cortex of kidney—kidney cancer	0.000179	0.00596	CbGeAlD
Cisplatin—BCHE—nephron tubule—kidney cancer	0.000158	0.00525	CbGeAlD
Cisplatin—ABCG2—nephron tubule—kidney cancer	0.000153	0.00507	CbGeAlD
Cisplatin—CYP2B6—nephron tubule—kidney cancer	0.000141	0.00468	CbGeAlD
Cisplatin—BCHE—cardiac atrium—kidney cancer	0.000129	0.00427	CbGeAlD
Cisplatin—CYP2B6—renal system—kidney cancer	0.000128	0.00426	CbGeAlD
Cisplatin—CYP2B6—kidney—kidney cancer	0.000124	0.00411	CbGeAlD
Cisplatin—CYP2B6—gonad—kidney cancer	0.000115	0.00382	CbGeAlD
Cisplatin—PTGS2—renal system—kidney cancer	0.000111	0.00368	CbGeAlD
Cisplatin—PTGS2—kidney—kidney cancer	0.000107	0.00356	CbGeAlD
Cisplatin—ABCB1—nephron tubule—kidney cancer	7.53e-05	0.0025	CbGeAlD
Cisplatin—ABCB1—renal system—kidney cancer	6.85e-05	0.00227	CbGeAlD
Cisplatin—ABCB1—kidney—kidney cancer	6.62e-05	0.0022	CbGeAlD
Cisplatin—ABCB1—cortex of kidney—kidney cancer	6.45e-05	0.00214	CbGeAlD
Cisplatin—ABCB1—gonad—kidney cancer	6.14e-05	0.00204	CbGeAlD
Cisplatin—Myalgia—Gemcitabine—kidney cancer	3.36e-05	0.000458	CcSEcCtD
Cisplatin—Alopecia—Paclitaxel—kidney cancer	3.35e-05	0.000457	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	3.34e-05	0.000455	CcSEcCtD
Cisplatin—Nervous system disorder—Vincristine—kidney cancer	3.33e-05	0.000454	CcSEcCtD
Cisplatin—Asthenia—Erlotinib—kidney cancer	3.33e-05	0.000454	CcSEcCtD
Cisplatin—Thrombocytopenia—Vincristine—kidney cancer	3.32e-05	0.000453	CcSEcCtD
Cisplatin—Discomfort—Gemcitabine—kidney cancer	3.32e-05	0.000453	CcSEcCtD
Cisplatin—Erythema—Paclitaxel—kidney cancer	3.3e-05	0.000451	CcSEcCtD
Cisplatin—Malnutrition—Paclitaxel—kidney cancer	3.3e-05	0.000451	CcSEcCtD
Cisplatin—Decreased appetite—Dactinomycin—kidney cancer	3.3e-05	0.000451	CcSEcCtD
Cisplatin—Diarrhoea—Vinblastine—kidney cancer	3.3e-05	0.00045	CcSEcCtD
Cisplatin—Body temperature increased—Sorafenib—kidney cancer	3.3e-05	0.00045	CcSEcCtD
Cisplatin—Diarrhoea—Everolimus—kidney cancer	3.29e-05	0.000448	CcSEcCtD
Cisplatin—Hyperhidrosis—Vincristine—kidney cancer	3.28e-05	0.000448	CcSEcCtD
Cisplatin—Hepatobiliary disease—Capecitabine—kidney cancer	3.28e-05	0.000448	CcSEcCtD
Cisplatin—Flatulence—Paclitaxel—kidney cancer	3.26e-05	0.000444	CcSEcCtD
Cisplatin—Pain—Dactinomycin—kidney cancer	3.25e-05	0.000443	CcSEcCtD
Cisplatin—Anorexia—Vincristine—kidney cancer	3.24e-05	0.000441	CcSEcCtD
Cisplatin—Oedema—Gemcitabine—kidney cancer	3.22e-05	0.000439	CcSEcCtD
Cisplatin—Anaphylactic shock—Gemcitabine—kidney cancer	3.22e-05	0.000439	CcSEcCtD
Cisplatin—Cardiac failure congestive—Doxorubicin—kidney cancer	3.2e-05	0.000437	CcSEcCtD
Cisplatin—Infection—Gemcitabine—kidney cancer	3.2e-05	0.000436	CcSEcCtD
Cisplatin—Muscle spasms—Paclitaxel—kidney cancer	3.18e-05	0.000433	CcSEcCtD
Cisplatin—Body temperature increased—Sunitinib—kidney cancer	3.17e-05	0.000433	CcSEcCtD
Cisplatin—Diarrhoea—Erlotinib—kidney cancer	3.17e-05	0.000433	CcSEcCtD
Cisplatin—Hypotension—Vincristine—kidney cancer	3.17e-05	0.000433	CcSEcCtD
Cisplatin—Bradycardia—Capecitabine—kidney cancer	3.17e-05	0.000433	CcSEcCtD
Cisplatin—Nervous system disorder—Gemcitabine—kidney cancer	3.16e-05	0.000431	CcSEcCtD
Cisplatin—Thrombocytopenia—Gemcitabine—kidney cancer	3.15e-05	0.00043	CcSEcCtD
Cisplatin—Renal failure acute—Doxorubicin—kidney cancer	3.14e-05	0.000429	CcSEcCtD
Cisplatin—Feeling abnormal—Dactinomycin—kidney cancer	3.13e-05	0.000427	CcSEcCtD
Cisplatin—Skin disorder—Gemcitabine—kidney cancer	3.13e-05	0.000427	CcSEcCtD
Cisplatin—Vision blurred—Paclitaxel—kidney cancer	3.11e-05	0.000425	CcSEcCtD
Cisplatin—Hyperhidrosis—Gemcitabine—kidney cancer	3.11e-05	0.000425	CcSEcCtD
Cisplatin—Tremor—Paclitaxel—kidney cancer	3.1e-05	0.000422	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Vincristine—kidney cancer	3.09e-05	0.000422	CcSEcCtD
Cisplatin—Urinary tract disorder—Capecitabine—kidney cancer	3.08e-05	0.00042	CcSEcCtD
Cisplatin—Hypersensitivity—Sorafenib—kidney cancer	3.07e-05	0.000419	CcSEcCtD
Cisplatin—Anorexia—Gemcitabine—kidney cancer	3.07e-05	0.000419	CcSEcCtD
Cisplatin—Vomiting—Vinblastine—kidney cancer	3.07e-05	0.000418	CcSEcCtD
Cisplatin—Ill-defined disorder—Paclitaxel—kidney cancer	3.07e-05	0.000418	CcSEcCtD
Cisplatin—Connective tissue disorder—Capecitabine—kidney cancer	3.06e-05	0.000418	CcSEcCtD
Cisplatin—Vomiting—Everolimus—kidney cancer	3.06e-05	0.000417	CcSEcCtD
Cisplatin—Anaemia—Paclitaxel—kidney cancer	3.05e-05	0.000417	CcSEcCtD
Cisplatin—Urethral disorder—Capecitabine—kidney cancer	3.05e-05	0.000416	CcSEcCtD
Cisplatin—Paraesthesia—Vincristine—kidney cancer	3.05e-05	0.000416	CcSEcCtD
Cisplatin—Rash—Everolimus—kidney cancer	3.03e-05	0.000413	CcSEcCtD
Cisplatin—Dermatitis—Everolimus—kidney cancer	3.03e-05	0.000413	CcSEcCtD
Cisplatin—Hypotension—Gemcitabine—kidney cancer	3.01e-05	0.000411	CcSEcCtD
Cisplatin—Body temperature increased—Dactinomycin—kidney cancer	3e-05	0.00041	CcSEcCtD
Cisplatin—Visual impairment—Capecitabine—kidney cancer	3e-05	0.000409	CcSEcCtD
Cisplatin—Anaphylactoid reaction—Doxorubicin—kidney cancer	3e-05	0.000409	CcSEcCtD
Cisplatin—Asthenia—Sorafenib—kidney cancer	2.99e-05	0.000408	CcSEcCtD
Cisplatin—Malaise—Paclitaxel—kidney cancer	2.98e-05	0.000406	CcSEcCtD
Cisplatin—Cerebrovascular accident—Doxorubicin—kidney cancer	2.96e-05	0.000404	CcSEcCtD
Cisplatin—Leukopenia—Paclitaxel—kidney cancer	2.96e-05	0.000403	CcSEcCtD
Cisplatin—Hypersensitivity—Sunitinib—kidney cancer	2.96e-05	0.000403	CcSEcCtD
Cisplatin—Decreased appetite—Vincristine—kidney cancer	2.95e-05	0.000403	CcSEcCtD
Cisplatin—Vomiting—Erlotinib—kidney cancer	2.95e-05	0.000402	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Gemcitabine—kidney cancer	2.93e-05	0.0004	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Vincristine—kidney cancer	2.93e-05	0.0004	CcSEcCtD
Cisplatin—Rash—Erlotinib—kidney cancer	2.92e-05	0.000399	CcSEcCtD
Cisplatin—Dermatitis—Erlotinib—kidney cancer	2.92e-05	0.000398	CcSEcCtD
Cisplatin—Hyponatraemia—Doxorubicin—kidney cancer	2.91e-05	0.000397	CcSEcCtD
Cisplatin—Eye disorder—Capecitabine—kidney cancer	2.91e-05	0.000397	CcSEcCtD
Cisplatin—Tinnitus—Capecitabine—kidney cancer	2.9e-05	0.000396	CcSEcCtD
Cisplatin—Pain—Vincristine—kidney cancer	2.9e-05	0.000396	CcSEcCtD
Cisplatin—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	2.9e-05	0.000396	CcSEcCtD
Cisplatin—Paraesthesia—Gemcitabine—kidney cancer	2.89e-05	0.000394	CcSEcCtD
Cisplatin—Flushing—Capecitabine—kidney cancer	2.89e-05	0.000394	CcSEcCtD
Cisplatin—Cardiac disorder—Capecitabine—kidney cancer	2.89e-05	0.000394	CcSEcCtD
Cisplatin—Asthenia—Sunitinib—kidney cancer	2.88e-05	0.000393	CcSEcCtD
Cisplatin—Dyspnoea—Gemcitabine—kidney cancer	2.87e-05	0.000392	CcSEcCtD
Cisplatin—Nausea—Vinblastine—kidney cancer	2.87e-05	0.000391	CcSEcCtD
Cisplatin—Convulsion—Paclitaxel—kidney cancer	2.86e-05	0.00039	CcSEcCtD
Cisplatin—Nausea—Everolimus—kidney cancer	2.85e-05	0.000389	CcSEcCtD
Cisplatin—Diarrhoea—Sorafenib—kidney cancer	2.85e-05	0.000389	CcSEcCtD
Cisplatin—Immune system disorder—Capecitabine—kidney cancer	2.81e-05	0.000384	CcSEcCtD
Cisplatin—Myalgia—Paclitaxel—kidney cancer	2.81e-05	0.000384	CcSEcCtD
Cisplatin—Mediastinal disorder—Capecitabine—kidney cancer	2.81e-05	0.000383	CcSEcCtD
Cisplatin—Anxiety—Paclitaxel—kidney cancer	2.8e-05	0.000382	CcSEcCtD
Cisplatin—Face oedema—Doxorubicin—kidney cancer	2.8e-05	0.000382	CcSEcCtD
Cisplatin—Decreased appetite—Gemcitabine—kidney cancer	2.8e-05	0.000382	CcSEcCtD
Cisplatin—Hypersensitivity—Dactinomycin—kidney cancer	2.8e-05	0.000382	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	2.79e-05	0.000381	CcSEcCtD
Cisplatin—Arrhythmia—Capecitabine—kidney cancer	2.78e-05	0.00038	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Gemcitabine—kidney cancer	2.78e-05	0.000379	CcSEcCtD
Cisplatin—Discomfort—Paclitaxel—kidney cancer	2.78e-05	0.000379	CcSEcCtD
Cisplatin—Pain—Gemcitabine—kidney cancer	2.75e-05	0.000376	CcSEcCtD
Cisplatin—Nausea—Erlotinib—kidney cancer	2.75e-05	0.000376	CcSEcCtD
Cisplatin—Alopecia—Capecitabine—kidney cancer	2.75e-05	0.000375	CcSEcCtD
Cisplatin—Diarrhoea—Sunitinib—kidney cancer	2.75e-05	0.000375	CcSEcCtD
Cisplatin—Asthenia—Dactinomycin—kidney cancer	2.73e-05	0.000372	CcSEcCtD
Cisplatin—Blood creatinine increased—Doxorubicin—kidney cancer	2.72e-05	0.000371	CcSEcCtD
Cisplatin—Malnutrition—Capecitabine—kidney cancer	2.71e-05	0.00037	CcSEcCtD
Cisplatin—Erythema—Capecitabine—kidney cancer	2.71e-05	0.00037	CcSEcCtD
Cisplatin—Dehydration—Doxorubicin—kidney cancer	2.7e-05	0.000368	CcSEcCtD
Cisplatin—Oedema—Paclitaxel—kidney cancer	2.7e-05	0.000368	CcSEcCtD
Cisplatin—Anaphylactic shock—Paclitaxel—kidney cancer	2.7e-05	0.000368	CcSEcCtD
Cisplatin—Body temperature increased—Vincristine—kidney cancer	2.68e-05	0.000366	CcSEcCtD
Cisplatin—Infection—Paclitaxel—kidney cancer	2.68e-05	0.000365	CcSEcCtD
Cisplatin—Flatulence—Capecitabine—kidney cancer	2.67e-05	0.000364	CcSEcCtD
Cisplatin—Feeling abnormal—Gemcitabine—kidney cancer	2.65e-05	0.000362	CcSEcCtD
Cisplatin—Vomiting—Sorafenib—kidney cancer	2.65e-05	0.000362	CcSEcCtD
Cisplatin—Orthostatic hypotension—Doxorubicin—kidney cancer	2.65e-05	0.000362	CcSEcCtD
Cisplatin—Nervous system disorder—Paclitaxel—kidney cancer	2.64e-05	0.000361	CcSEcCtD
Cisplatin—Hypokalaemia—Doxorubicin—kidney cancer	2.64e-05	0.00036	CcSEcCtD
Cisplatin—Thrombocytopenia—Paclitaxel—kidney cancer	2.64e-05	0.00036	CcSEcCtD
Cisplatin—Tachycardia—Paclitaxel—kidney cancer	2.63e-05	0.000359	CcSEcCtD
Cisplatin—Rash—Sorafenib—kidney cancer	2.63e-05	0.000359	CcSEcCtD
Cisplatin—Dermatitis—Sorafenib—kidney cancer	2.63e-05	0.000358	CcSEcCtD
Cisplatin—Breast disorder—Doxorubicin—kidney cancer	2.62e-05	0.000358	CcSEcCtD
Cisplatin—Skin disorder—Paclitaxel—kidney cancer	2.62e-05	0.000357	CcSEcCtD
Cisplatin—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	2.61e-05	0.000356	CcSEcCtD
Cisplatin—Muscle spasms—Capecitabine—kidney cancer	2.61e-05	0.000356	CcSEcCtD
Cisplatin—Hyperhidrosis—Paclitaxel—kidney cancer	2.61e-05	0.000356	CcSEcCtD
Cisplatin—Diarrhoea—Dactinomycin—kidney cancer	2.6e-05	0.000355	CcSEcCtD
Cisplatin—Nasopharyngitis—Doxorubicin—kidney cancer	2.6e-05	0.000354	CcSEcCtD
Cisplatin—Anorexia—Paclitaxel—kidney cancer	2.57e-05	0.000351	CcSEcCtD
Cisplatin—Vision blurred—Capecitabine—kidney cancer	2.56e-05	0.000349	CcSEcCtD
Cisplatin—Vomiting—Sunitinib—kidney cancer	2.55e-05	0.000348	CcSEcCtD
Cisplatin—Body temperature increased—Gemcitabine—kidney cancer	2.55e-05	0.000347	CcSEcCtD
Cisplatin—Tremor—Capecitabine—kidney cancer	2.54e-05	0.000347	CcSEcCtD
Cisplatin—Rash—Sunitinib—kidney cancer	2.53e-05	0.000345	CcSEcCtD
Cisplatin—Dermatitis—Sunitinib—kidney cancer	2.53e-05	0.000345	CcSEcCtD
Cisplatin—Hypotension—Paclitaxel—kidney cancer	2.52e-05	0.000344	CcSEcCtD
Cisplatin—Ill-defined disorder—Capecitabine—kidney cancer	2.52e-05	0.000343	CcSEcCtD
Cisplatin—Anaemia—Capecitabine—kidney cancer	2.51e-05	0.000342	CcSEcCtD
Cisplatin—Hypersensitivity—Vincristine—kidney cancer	2.5e-05	0.000341	CcSEcCtD
Cisplatin—Nausea—Sorafenib—kidney cancer	2.48e-05	0.000338	CcSEcCtD
Cisplatin—Pancreatitis—Doxorubicin—kidney cancer	2.46e-05	0.000335	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Paclitaxel—kidney cancer	2.46e-05	0.000335	CcSEcCtD
Cisplatin—Malaise—Capecitabine—kidney cancer	2.45e-05	0.000334	CcSEcCtD
Cisplatin—Asthenia—Vincristine—kidney cancer	2.44e-05	0.000332	CcSEcCtD
Cisplatin—Leukopenia—Capecitabine—kidney cancer	2.43e-05	0.000331	CcSEcCtD
Cisplatin—Paraesthesia—Paclitaxel—kidney cancer	2.42e-05	0.00033	CcSEcCtD
Cisplatin—Vomiting—Dactinomycin—kidney cancer	2.42e-05	0.00033	CcSEcCtD
Cisplatin—Dyspnoea—Paclitaxel—kidney cancer	2.4e-05	0.000328	CcSEcCtD
Cisplatin—Rash—Dactinomycin—kidney cancer	2.4e-05	0.000327	CcSEcCtD
Cisplatin—Nausea—Sunitinib—kidney cancer	2.38e-05	0.000325	CcSEcCtD
Cisplatin—Pancytopenia—Doxorubicin—kidney cancer	2.38e-05	0.000325	CcSEcCtD
Cisplatin—Decreased appetite—Paclitaxel—kidney cancer	2.34e-05	0.00032	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Paclitaxel—kidney cancer	2.33e-05	0.000318	CcSEcCtD
Cisplatin—Diarrhoea—Vincristine—kidney cancer	2.32e-05	0.000317	CcSEcCtD
Cisplatin—Asthenia—Gemcitabine—kidney cancer	2.31e-05	0.000315	CcSEcCtD
Cisplatin—Myalgia—Capecitabine—kidney cancer	2.31e-05	0.000315	CcSEcCtD
Cisplatin—Pain—Paclitaxel—kidney cancer	2.31e-05	0.000315	CcSEcCtD
Cisplatin—Anxiety—Capecitabine—kidney cancer	2.3e-05	0.000314	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	2.29e-05	0.000313	CcSEcCtD
Cisplatin—Discomfort—Capecitabine—kidney cancer	2.28e-05	0.000311	CcSEcCtD
Cisplatin—Nausea—Dactinomycin—kidney cancer	2.26e-05	0.000308	CcSEcCtD
Cisplatin—Feeling abnormal—Paclitaxel—kidney cancer	2.22e-05	0.000303	CcSEcCtD
Cisplatin—Oedema—Capecitabine—kidney cancer	2.21e-05	0.000302	CcSEcCtD
Cisplatin—Diarrhoea—Gemcitabine—kidney cancer	2.2e-05	0.000301	CcSEcCtD
Cisplatin—Renal failure—Doxorubicin—kidney cancer	2.2e-05	0.0003	CcSEcCtD
Cisplatin—Infection—Capecitabine—kidney cancer	2.2e-05	0.0003	CcSEcCtD
Cisplatin—Neuropathy peripheral—Doxorubicin—kidney cancer	2.19e-05	0.000299	CcSEcCtD
Cisplatin—Stomatitis—Doxorubicin—kidney cancer	2.18e-05	0.000297	CcSEcCtD
Cisplatin—Conjunctivitis—Doxorubicin—kidney cancer	2.17e-05	0.000297	CcSEcCtD
Cisplatin—Nervous system disorder—Capecitabine—kidney cancer	2.17e-05	0.000296	CcSEcCtD
Cisplatin—Thrombocytopenia—Capecitabine—kidney cancer	2.17e-05	0.000296	CcSEcCtD
Cisplatin—Tachycardia—Capecitabine—kidney cancer	2.16e-05	0.000295	CcSEcCtD
Cisplatin—Vomiting—Vincristine—kidney cancer	2.16e-05	0.000294	CcSEcCtD
Cisplatin—Skin disorder—Capecitabine—kidney cancer	2.15e-05	0.000293	CcSEcCtD
Cisplatin—Rash—Vincristine—kidney cancer	2.14e-05	0.000292	CcSEcCtD
Cisplatin—Hyperhidrosis—Capecitabine—kidney cancer	2.14e-05	0.000292	CcSEcCtD
Cisplatin—Dermatitis—Vincristine—kidney cancer	2.14e-05	0.000292	CcSEcCtD
Cisplatin—Body temperature increased—Paclitaxel—kidney cancer	2.13e-05	0.000291	CcSEcCtD
Cisplatin—Hepatobiliary disease—Doxorubicin—kidney cancer	2.12e-05	0.000289	CcSEcCtD
Cisplatin—Anorexia—Capecitabine—kidney cancer	2.11e-05	0.000288	CcSEcCtD
Cisplatin—Hypotension—Capecitabine—kidney cancer	2.07e-05	0.000282	CcSEcCtD
Cisplatin—Vomiting—Gemcitabine—kidney cancer	2.05e-05	0.000279	CcSEcCtD
Cisplatin—Bradycardia—Doxorubicin—kidney cancer	2.04e-05	0.000279	CcSEcCtD
Cisplatin—Rash—Gemcitabine—kidney cancer	2.03e-05	0.000277	CcSEcCtD
Cisplatin—Dermatitis—Gemcitabine—kidney cancer	2.03e-05	0.000277	CcSEcCtD
Cisplatin—Nausea—Vincristine—kidney cancer	2.02e-05	0.000275	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Capecitabine—kidney cancer	2.02e-05	0.000275	CcSEcCtD
Cisplatin—Paraesthesia—Capecitabine—kidney cancer	1.99e-05	0.000271	CcSEcCtD
Cisplatin—Hypersensitivity—Paclitaxel—kidney cancer	1.99e-05	0.000271	CcSEcCtD
Cisplatin—Urinary tract disorder—Doxorubicin—kidney cancer	1.98e-05	0.00027	CcSEcCtD
Cisplatin—Connective tissue disorder—Doxorubicin—kidney cancer	1.97e-05	0.000269	CcSEcCtD
Cisplatin—Dyspnoea—Capecitabine—kidney cancer	1.97e-05	0.000269	CcSEcCtD
Cisplatin—Urethral disorder—Doxorubicin—kidney cancer	1.97e-05	0.000268	CcSEcCtD
Cisplatin—Visual impairment—Doxorubicin—kidney cancer	1.94e-05	0.000264	CcSEcCtD
Cisplatin—Asthenia—Paclitaxel—kidney cancer	1.93e-05	0.000264	CcSEcCtD
Cisplatin—Decreased appetite—Capecitabine—kidney cancer	1.92e-05	0.000262	CcSEcCtD
Cisplatin—Nausea—Gemcitabine—kidney cancer	1.91e-05	0.000261	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Capecitabine—kidney cancer	1.91e-05	0.000261	CcSEcCtD
Cisplatin—Pain—Capecitabine—kidney cancer	1.89e-05	0.000258	CcSEcCtD
Cisplatin—Eye disorder—Doxorubicin—kidney cancer	1.88e-05	0.000256	CcSEcCtD
Cisplatin—Tinnitus—Doxorubicin—kidney cancer	1.87e-05	0.000255	CcSEcCtD
Cisplatin—Cardiac disorder—Doxorubicin—kidney cancer	1.86e-05	0.000254	CcSEcCtD
Cisplatin—Flushing—Doxorubicin—kidney cancer	1.86e-05	0.000254	CcSEcCtD
Cisplatin—Diarrhoea—Paclitaxel—kidney cancer	1.85e-05	0.000252	CcSEcCtD
Cisplatin—Feeling abnormal—Capecitabine—kidney cancer	1.82e-05	0.000249	CcSEcCtD
Cisplatin—Immune system disorder—Doxorubicin—kidney cancer	1.81e-05	0.000247	CcSEcCtD
Cisplatin—Mediastinal disorder—Doxorubicin—kidney cancer	1.81e-05	0.000247	CcSEcCtD
Cisplatin—Arrhythmia—Doxorubicin—kidney cancer	1.79e-05	0.000245	CcSEcCtD
Cisplatin—Alopecia—Doxorubicin—kidney cancer	1.77e-05	0.000242	CcSEcCtD
Cisplatin—Body temperature increased—Capecitabine—kidney cancer	1.75e-05	0.000239	CcSEcCtD
Cisplatin—Erythema—Doxorubicin—kidney cancer	1.75e-05	0.000238	CcSEcCtD
Cisplatin—Malnutrition—Doxorubicin—kidney cancer	1.75e-05	0.000238	CcSEcCtD
Cisplatin—Flatulence—Doxorubicin—kidney cancer	1.72e-05	0.000235	CcSEcCtD
Cisplatin—Vomiting—Paclitaxel—kidney cancer	1.71e-05	0.000234	CcSEcCtD
Cisplatin—Rash—Paclitaxel—kidney cancer	1.7e-05	0.000232	CcSEcCtD
Cisplatin—Dermatitis—Paclitaxel—kidney cancer	1.7e-05	0.000232	CcSEcCtD
Cisplatin—Muscle spasms—Doxorubicin—kidney cancer	1.68e-05	0.000229	CcSEcCtD
Cisplatin—Vision blurred—Doxorubicin—kidney cancer	1.65e-05	0.000225	CcSEcCtD
Cisplatin—Hypersensitivity—Capecitabine—kidney cancer	1.63e-05	0.000222	CcSEcCtD
Cisplatin—Ill-defined disorder—Doxorubicin—kidney cancer	1.62e-05	0.000221	CcSEcCtD
Cisplatin—Anaemia—Doxorubicin—kidney cancer	1.62e-05	0.00022	CcSEcCtD
Cisplatin—Nausea—Paclitaxel—kidney cancer	1.6e-05	0.000218	CcSEcCtD
Cisplatin—Asthenia—Capecitabine—kidney cancer	1.59e-05	0.000217	CcSEcCtD
Cisplatin—Malaise—Doxorubicin—kidney cancer	1.58e-05	0.000215	CcSEcCtD
Cisplatin—Leukopenia—Doxorubicin—kidney cancer	1.56e-05	0.000213	CcSEcCtD
Cisplatin—Convulsion—Doxorubicin—kidney cancer	1.51e-05	0.000207	CcSEcCtD
Cisplatin—Diarrhoea—Capecitabine—kidney cancer	1.51e-05	0.000207	CcSEcCtD
Cisplatin—Myalgia—Doxorubicin—kidney cancer	1.49e-05	0.000203	CcSEcCtD
Cisplatin—Anxiety—Doxorubicin—kidney cancer	1.48e-05	0.000202	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	1.48e-05	0.000202	CcSEcCtD
Cisplatin—Discomfort—Doxorubicin—kidney cancer	1.47e-05	0.000201	CcSEcCtD
Cisplatin—Anaphylactic shock—Doxorubicin—kidney cancer	1.43e-05	0.000195	CcSEcCtD
Cisplatin—Oedema—Doxorubicin—kidney cancer	1.43e-05	0.000195	CcSEcCtD
Cisplatin—Infection—Doxorubicin—kidney cancer	1.42e-05	0.000193	CcSEcCtD
Cisplatin—Vomiting—Capecitabine—kidney cancer	1.41e-05	0.000192	CcSEcCtD
Cisplatin—Nervous system disorder—Doxorubicin—kidney cancer	1.4e-05	0.000191	CcSEcCtD
Cisplatin—Thrombocytopenia—Doxorubicin—kidney cancer	1.4e-05	0.000191	CcSEcCtD
Cisplatin—Rash—Capecitabine—kidney cancer	1.4e-05	0.00019	CcSEcCtD
Cisplatin—Dermatitis—Capecitabine—kidney cancer	1.39e-05	0.00019	CcSEcCtD
Cisplatin—Tachycardia—Doxorubicin—kidney cancer	1.39e-05	0.00019	CcSEcCtD
Cisplatin—Skin disorder—Doxorubicin—kidney cancer	1.39e-05	0.000189	CcSEcCtD
Cisplatin—Hyperhidrosis—Doxorubicin—kidney cancer	1.38e-05	0.000188	CcSEcCtD
Cisplatin—Anorexia—Doxorubicin—kidney cancer	1.36e-05	0.000185	CcSEcCtD
Cisplatin—Hypotension—Doxorubicin—kidney cancer	1.33e-05	0.000182	CcSEcCtD
Cisplatin—Nausea—Capecitabine—kidney cancer	1.31e-05	0.000179	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Doxorubicin—kidney cancer	1.3e-05	0.000177	CcSEcCtD
Cisplatin—Paraesthesia—Doxorubicin—kidney cancer	1.28e-05	0.000175	CcSEcCtD
Cisplatin—Dyspnoea—Doxorubicin—kidney cancer	1.27e-05	0.000173	CcSEcCtD
Cisplatin—Decreased appetite—Doxorubicin—kidney cancer	1.24e-05	0.000169	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Doxorubicin—kidney cancer	1.23e-05	0.000168	CcSEcCtD
Cisplatin—Pain—Doxorubicin—kidney cancer	1.22e-05	0.000166	CcSEcCtD
Cisplatin—Feeling abnormal—Doxorubicin—kidney cancer	1.18e-05	0.00016	CcSEcCtD
Cisplatin—Body temperature increased—Doxorubicin—kidney cancer	1.13e-05	0.000154	CcSEcCtD
Cisplatin—Hypersensitivity—Doxorubicin—kidney cancer	1.05e-05	0.000143	CcSEcCtD
Cisplatin—Asthenia—Doxorubicin—kidney cancer	1.02e-05	0.00014	CcSEcCtD
Cisplatin—Diarrhoea—Doxorubicin—kidney cancer	9.76e-06	0.000133	CcSEcCtD
Cisplatin—Vomiting—Doxorubicin—kidney cancer	9.07e-06	0.000124	CcSEcCtD
Cisplatin—Rash—Doxorubicin—kidney cancer	9e-06	0.000123	CcSEcCtD
Cisplatin—Dermatitis—Doxorubicin—kidney cancer	8.99e-06	0.000123	CcSEcCtD
Cisplatin—Nausea—Doxorubicin—kidney cancer	8.47e-06	0.000116	CcSEcCtD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	3.28e-06	7.61e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.26e-06	7.57e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CA9—kidney cancer	3.25e-06	7.54e-05	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—POMC—kidney cancer	3.25e-06	7.53e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—SCARB1—kidney cancer	3.22e-06	7.47e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—BRAF—kidney cancer	3.21e-06	7.44e-05	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	3.21e-06	7.44e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	3.21e-06	7.44e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PTGS1—kidney cancer	3.19e-06	7.4e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	3.18e-06	7.37e-05	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—POMC—kidney cancer	3.16e-06	7.34e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—CYP1A1—kidney cancer	3.16e-06	7.34e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.13e-06	7.27e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PSMD7—kidney cancer	3.13e-06	7.26e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GPC3—kidney cancer	3.13e-06	7.25e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CA9—kidney cancer	3.12e-06	7.25e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—APRT—kidney cancer	3.11e-06	7.2e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—FH—kidney cancer	3.11e-06	7.2e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—GSTP1—kidney cancer	3.09e-06	7.16e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Neuronal System—MAPK1—kidney cancer	3.07e-06	7.13e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—GSTT1—kidney cancer	3.07e-06	7.13e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—ACHE—kidney cancer	3.07e-06	7.13e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—ITPR2—kidney cancer	3.07e-06	7.12e-05	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	3.05e-06	7.08e-05	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—PTGS2—kidney cancer	3.05e-06	7.07e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—GSTT1—kidney cancer	3.04e-06	7.05e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CA2—kidney cancer	3.04e-06	7.05e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—ACHE—kidney cancer	3.04e-06	7.05e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	3.04e-06	7.05e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.04e-06	7.04e-05	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	3.03e-06	7.03e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—POMC—kidney cancer	2.97e-06	6.9e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ALAD—kidney cancer	2.96e-06	6.87e-05	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	2.95e-06	6.84e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—SLC5A5—kidney cancer	2.93e-06	6.79e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—ABCB1—kidney cancer	2.92e-06	6.78e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GPC3—kidney cancer	2.92e-06	6.77e-05	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—PIK3CA—kidney cancer	2.91e-06	6.75e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—SCARB1—kidney cancer	2.91e-06	6.75e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	2.9e-06	6.72e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ST3GAL2—kidney cancer	2.89e-06	6.71e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	2.89e-06	6.71e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PTGS1—kidney cancer	2.88e-06	6.68e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—SCARB1—kidney cancer	2.88e-06	6.68e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	2.87e-06	6.66e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PTGS1—kidney cancer	2.85e-06	6.61e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CA2—kidney cancer	2.84e-06	6.59e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—POMC—kidney cancer	2.84e-06	6.58e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—GSTM1—kidney cancer	2.84e-06	6.58e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—SLC2A1—kidney cancer	2.83e-06	6.56e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ALDH1A1—kidney cancer	2.83e-06	6.56e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PSMD7—kidney cancer	2.82e-06	6.55e-05	CbGpPWpGaD
Cisplatin—ABCC2—Transmembrane transport of small molecules—RAF1—kidney cancer	2.8e-06	6.49e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	2.8e-06	6.49e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PSMD7—kidney cancer	2.79e-06	6.48e-05	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	2.78e-06	6.46e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ALAD—kidney cancer	2.77e-06	6.42e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CRABP1—kidney cancer	2.76e-06	6.41e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.74e-06	6.37e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—POMC—kidney cancer	2.72e-06	6.31e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PGK1—kidney cancer	2.71e-06	6.29e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—SLC5A3—kidney cancer	2.71e-06	6.29e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ST3GAL2—kidney cancer	2.7e-06	6.27e-05	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	2.69e-06	6.25e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—CYP1A1—kidney cancer	2.69e-06	6.24e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—RAF1—kidney cancer	2.68e-06	6.21e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—BCHE—kidney cancer	2.68e-06	6.21e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—LDHB—kidney cancer	2.66e-06	6.16e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CRABP1—kidney cancer	2.66e-06	6.16e-05	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—PTEN—kidney cancer	2.66e-06	6.16e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—ERBB2—kidney cancer	2.65e-06	6.15e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—BCHE—kidney cancer	2.65e-06	6.14e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—SLC5A5—kidney cancer	2.64e-06	6.13e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ALDH1A1—kidney cancer	2.64e-06	6.12e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—SLC5A5—kidney cancer	2.62e-06	6.07e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—MTOR—kidney cancer	2.62e-06	6.07e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CD4—kidney cancer	2.61e-06	6.06e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.6e-06	6.03e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—PTGS2—kidney cancer	2.59e-06	6.01e-05	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PTGS2—kidney cancer	2.59e-06	6.01e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PSMD7—kidney cancer	2.57e-06	5.96e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—ITPR2—kidney cancer	2.57e-06	5.96e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—SLC2A1—kidney cancer	2.55e-06	5.92e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—SLC5A3—kidney cancer	2.53e-06	5.87e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PGK1—kidney cancer	2.53e-06	5.87e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—SLC2A1—kidney cancer	2.53e-06	5.86e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	2.53e-06	5.86e-05	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PTGS2—kidney cancer	2.52e-06	5.85e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—LDHB—kidney cancer	2.48e-06	5.76e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—ITPR2—kidney cancer	2.47e-06	5.73e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CDKN1B—kidney cancer	2.45e-06	5.69e-05	CbGpPWpGaD
Cisplatin—ABCG2—Transmembrane transport of small molecules—RAF1—kidney cancer	2.43e-06	5.65e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Transmembrane transport of small molecules—RAF1—kidney cancer	2.41e-06	5.59e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.39e-06	5.55e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	2.39e-06	5.54e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.37e-06	5.49e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—GSTP1—kidney cancer	2.36e-06	5.47e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—POMC—kidney cancer	2.36e-06	5.47e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GSTT1—kidney cancer	2.34e-06	5.44e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—ACHE—kidney cancer	2.34e-06	5.44e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—SLC2A1—kidney cancer	2.33e-06	5.39e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	2.32e-06	5.39e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CTNNB1—kidney cancer	2.32e-06	5.38e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—JUNB—kidney cancer	2.31e-06	5.35e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CA9—kidney cancer	2.3e-06	5.34e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	2.27e-06	5.27e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PTGS2—kidney cancer	2.26e-06	5.25e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—PTEN—kidney cancer	2.26e-06	5.24e-05	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PTEN—kidney cancer	2.26e-06	5.24e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—ACHE—kidney cancer	2.25e-06	5.22e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GSTT1—kidney cancer	2.25e-06	5.22e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—ABCB1—kidney cancer	2.23e-06	5.18e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—SCARB1—kidney cancer	2.22e-06	5.14e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.21e-06	5.13e-05	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PTEN—kidney cancer	2.2e-06	5.11e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PTGS1—kidney cancer	2.2e-06	5.09e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PTGS2—kidney cancer	2.17e-06	5.03e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—GSTM1—kidney cancer	2.17e-06	5.03e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PSMD7—kidney cancer	2.15e-06	4.99e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CA9—kidney cancer	2.15e-06	4.99e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	2.15e-06	4.98e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—SCARB1—kidney cancer	2.13e-06	4.94e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—GSTP1—kidney cancer	2.13e-06	4.94e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—CTNNB1—kidney cancer	2.12e-06	4.92e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PTGS1—kidney cancer	2.11e-06	4.89e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—GSTP1—kidney cancer	2.11e-06	4.89e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.1e-06	4.88e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PSMD7—kidney cancer	2.07e-06	4.8e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—CYP1A1—kidney cancer	2.06e-06	4.77e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—BCHE—kidney cancer	2.04e-06	4.73e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—SLC5A5—kidney cancer	2.02e-06	4.68e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—ABCB1—kidney cancer	2.02e-06	4.68e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—POMC—kidney cancer	2.01e-06	4.65e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—ABCB1—kidney cancer	1.99e-06	4.63e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PTEN—kidney cancer	1.97e-06	4.58e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.97e-06	4.58e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—BCHE—kidney cancer	1.96e-06	4.55e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CRABP1—kidney cancer	1.96e-06	4.54e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—GSTM1—kidney cancer	1.96e-06	4.54e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—SLC2A1—kidney cancer	1.95e-06	4.52e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—SLC5A5—kidney cancer	1.94e-06	4.49e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—GSTM1—kidney cancer	1.94e-06	4.49e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—MAPK3—kidney cancer	1.93e-06	4.48e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	1.91e-06	4.43e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PTEN—kidney cancer	1.89e-06	4.39e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PTGS2—kidney cancer	1.88e-06	4.36e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CDKN2B—kidney cancer	1.88e-06	4.36e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—MYC—kidney cancer	1.88e-06	4.36e-05	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—PIK3CA—kidney cancer	1.87e-06	4.35e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—SLC2A1—kidney cancer	1.87e-06	4.34e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—CYP1A1—kidney cancer	1.86e-06	4.3e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—MAPK1—kidney cancer	1.84e-06	4.26e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CYP1A1—kidney cancer	1.84e-06	4.26e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CRABP1—kidney cancer	1.83e-06	4.25e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ITPR2—kidney cancer	1.82e-06	4.22e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—KRAS—kidney cancer	1.74e-06	4.03e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ITPR2—kidney cancer	1.7e-06	3.95e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.69e-06	3.92e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—ACHE—kidney cancer	1.66e-06	3.85e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GSTT1—kidney cancer	1.66e-06	3.85e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.65e-06	3.82e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PTEN—kidney cancer	1.64e-06	3.81e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GSTP1—kidney cancer	1.62e-06	3.77e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PTGS2—kidney cancer	1.6e-06	3.71e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—PIK3CA—kidney cancer	1.59e-06	3.7e-05	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PIK3CA—kidney cancer	1.59e-06	3.7e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—SCARB1—kidney cancer	1.57e-06	3.65e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.57e-06	3.64e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GSTP1—kidney cancer	1.56e-06	3.62e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PTGS1—kidney cancer	1.56e-06	3.61e-05	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PIK3CA—kidney cancer	1.55e-06	3.6e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GSTT1—kidney cancer	1.55e-06	3.6e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ACHE—kidney cancer	1.55e-06	3.6e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—ABCB1—kidney cancer	1.54e-06	3.57e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—POMC—kidney cancer	1.53e-06	3.56e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PSMD7—kidney cancer	1.53e-06	3.54e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—HIF1A—kidney cancer	1.5e-06	3.48e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—TSC2—kidney cancer	1.5e-06	3.48e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—GSTM1—kidney cancer	1.49e-06	3.46e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—ABCB1—kidney cancer	1.48e-06	3.43e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—SCARB1—kidney cancer	1.47e-06	3.41e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PTGS1—kidney cancer	1.45e-06	3.37e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—BCHE—kidney cancer	1.45e-06	3.36e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—GSTM1—kidney cancer	1.43e-06	3.33e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—SLC5A5—kidney cancer	1.43e-06	3.32e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PSMD7—kidney cancer	1.43e-06	3.31e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CYP1A1—kidney cancer	1.41e-06	3.28e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PTEN—kidney cancer	1.4e-06	3.24e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PIK3CA—kidney cancer	1.39e-06	3.23e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—POMC—kidney cancer	1.38e-06	3.21e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—SLC2A1—kidney cancer	1.38e-06	3.2e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—POMC—kidney cancer	1.37e-06	3.18e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CYP1A1—kidney cancer	1.36e-06	3.15e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—BCHE—kidney cancer	1.35e-06	3.14e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PIK3CA—kidney cancer	1.34e-06	3.1e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—SLC5A5—kidney cancer	1.34e-06	3.1e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—KIT—kidney cancer	1.32e-06	3.07e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—APC—kidney cancer	1.32e-06	3.07e-05	CbGpPWpGaD
Cisplatin—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	1.32e-06	3.05e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—SLC2A1—kidney cancer	1.29e-06	2.99e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.25e-06	2.9e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—BRAF—kidney cancer	1.24e-06	2.89e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PTGS2—kidney cancer	1.22e-06	2.84e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.16e-06	2.7e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PIK3CA—kidney cancer	1.16e-06	2.69e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GSTP1—kidney cancer	1.15e-06	2.67e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PTGS2—kidney cancer	1.1e-06	2.56e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PTGS2—kidney cancer	1.09e-06	2.53e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.09e-06	2.53e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GSTP1—kidney cancer	1.08e-06	2.49e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PTEN—kidney cancer	1.07e-06	2.47e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—GSTM1—kidney cancer	1.06e-06	2.45e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—POMC—kidney cancer	1.05e-06	2.45e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—RAF1—kidney cancer	1.04e-06	2.41e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—ERBB2—kidney cancer	1.03e-06	2.38e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—ABCB1—kidney cancer	1.02e-06	2.36e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MTOR—kidney cancer	1.01e-06	2.35e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—POMC—kidney cancer	1.01e-06	2.35e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CD4—kidney cancer	1.01e-06	2.35e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYP1A1—kidney cancer	1e-06	2.33e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—GSTM1—kidney cancer	9.88e-07	2.29e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PIK3CA—kidney cancer	9.84e-07	2.28e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PTEN—kidney cancer	9.62e-07	2.23e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PTEN—kidney cancer	9.52e-07	2.21e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CDKN1B—kidney cancer	9.52e-07	2.21e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYP1A1—kidney cancer	9.37e-07	2.17e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CTNNB1—kidney cancer	8.99e-07	2.09e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PTEN—kidney cancer	8.76e-07	2.03e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PTGS2—kidney cancer	8.09e-07	1.88e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.7e-07	1.79e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PIK3CA—kidney cancer	7.52e-07	1.74e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MAPK3—kidney cancer	7.49e-07	1.74e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—POMC—kidney cancer	7.48e-07	1.73e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PTEN—kidney cancer	7.34e-07	1.7e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MYC—kidney cancer	7.28e-07	1.69e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MAPK1—kidney cancer	7.12e-07	1.65e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PTEN—kidney cancer	7.05e-07	1.64e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—POMC—kidney cancer	6.99e-07	1.62e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PIK3CA—kidney cancer	6.79e-07	1.57e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—KRAS—kidney cancer	6.73e-07	1.56e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PIK3CA—kidney cancer	6.72e-07	1.56e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PIK3CA—kidney cancer	6.18e-07	1.43e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PTGS2—kidney cancer	5.96e-07	1.38e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PTGS2—kidney cancer	5.57e-07	1.29e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PTEN—kidney cancer	5.2e-07	1.21e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PIK3CA—kidney cancer	5.18e-07	1.2e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PIK3CA—kidney cancer	4.98e-07	1.15e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PTEN—kidney cancer	4.86e-07	1.13e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PIK3CA—kidney cancer	3.67e-07	8.51e-06	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PIK3CA—kidney cancer	3.43e-07	7.95e-06	CbGpPWpGaD
